wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35136424-124883E3-5E93-4953-BD51-8D1A2BE853A2
Q35136424-124883E3-5E93-4953-BD51-8D1A2BE853A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35136424-124883E3-5E93-4953-BD51-8D1A2BE853A2
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014
P2860
Q35136424-124883E3-5E93-4953-BD51-8D1A2BE853A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35136424-124883E3-5E93-4953-BD51-8D1A2BE853A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1446468d132456b5b9a4c558c924d6fa75064b74
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.